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ABSTRACT
Insulin and Ketones: Their Roles in Brain Mitochondrial Function
Sheryl Teresa Carr
Department of Physiology and Developmental Biology, BYU
Master of Science
The prevalence of both Type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD)
is increasing worldwide, and the trends are unfortunately expected to continue. AD has recently
been tied with mitochondrial dysfunction and insulin resistance, creating a mechanistic tie
between AD and T2DM. Unfortunately, insulin resistance is often increased with aging and
therefore, all individuals are at risk of brain mitochondrial dysfunction. Without proper
mitochondrial function, the brain will degenerate, causing impaired cognitive function and
reduced quality of life. The purpose of this study is two-fold: first, to understand the role of
ceramides in insulin-induced brain mitochondrial dysfunction, and; second, to understand how
ketones can restore brain mitochondrial function in aged brains.
To evaluate the role of insulin resistance and ceramides in brain mitochondrial function,
we induced hyperinsulinemia in ApoE4 mice. In addition to insulin, one group received myriocin
injections to inhibit ceramide biosynthesis. We observed significant increases in brain ceramides
in the insulin-treated group, which correlated with disrupted brain mitochondrial function.
However, the group receiving myriocin alone, and, importantly, myriocin with insulin, had
normal lipid profiles and normal mitochondrial bioenergetics. Altogether, these findings support
the hypothesis of the key role of ceramides in insulin resistance-induced mitochondrial
dysfunction within the brain.
Next, young adult (5 months old) and old (28 months old) rats were assigned to either
standard chow diets or very-low-carbohydrate, high-fat, ketogenic diets for 4 weeks. Following
the treatment period, we analyzed brain mitochondrial function and oxidative stress. We found
that the old rats fed the ketogenic diet had improved mitochondrial function in comparison to the
old rats consuming standard rodent chow. In addition, the old rats fed a standard diet had
significantly higher levels of oxidative stress than the aged rats on the very-low-carbohydrate,
high-fat diet. These findings revealed that ketones can protect brain mitochondrial function in
aging.
Collectively, these results suggest that insulin resistance has a role in the development of
brain mitochondrial dysfunction due to ceramide accumulation, while ketones can help mitigate
some of the negative consequences of aging, perhaps some due to insulin resistance, on brain
mitochondrial function.
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CHAPTER 1: Introduction and Background
Insulin Signaling Within the Brain
The role of insulin within the brain is very different from that of peripheral tissues.
Various glucose transporters (GLUTs) are found throughout the brain, but insulin only affects
glucose transport in the hypothalamus, where there is the insulin-dependent transporter – GLUT4
(Ren et al., 2014). Unlike peripheral insulin receptors, insulin-mediated neuronal insulin
receptors and IGF-1 receptors within the brain regulate many physiological functions such as
food intake, inhibition of hepatic gluconeogenesis, counter-regulation of hypoglycemia,
modulation of tau protein phosphorylation, AβPP metabolism, Amyloid-β clearance, neuronal
survival, and memory (Candeias et al., 2012). Therefore, glucose uptake and metabolism within
the brain is one of many actions within neuronal function regulated by insulin.
Despite insulin’s lack of glucose regulation within the brain, its signaling cascade is still
important for other physiological functions within the brain, especially those with
neuroprotective effects. Binding of insulin or IGF-1 causes receptor auto-phosphorylation,
stimulating tyrosine kinase activity, which then causes phosphorylation of the insulin receptor
substrates on the tyrosine residues. This causes two main signaling cascades mediated by
phosphatidylinositol 3-kinase (PI3K)/AKT and mitogen-activated protein kinase (MAPK)
(Candeias et al., 2012).
AKT, along with its downstream effector CREB, has been shown to be a major
contributor of neuron formation, synaptic plasticity within the brain, learning, and memory
(Xiang et al., 2015). Another downstream signaling molecules of AKT is GSK3αβ, and
activation of AKT, protein kinase C, or c-AMP-dependent protein kinase can lead to the
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inactivation of GSK-3αβ. GSK3α increases the production of amyloid-beta while GSK3β is the
major tau kinase responsible for the hyperphosphorylation of tau and its formation of
neurofibrillary tangles. In addition, the inhibition of GSK-3β by AKT prevents apoptosis of
neurons and other glial cells (Candeias et al., 2012).
The MAPK pathway is the second pathway activated by insulin within the brain. This
promotes the expression of genes involved in cell and neuronal synapse growth as well as repair
and maintenance of cells within the brain. Some researchers have been bold enough to conclude
that insulin has vital neurotrophic and neuroprotective effects within the brain based on its
downstream effects of both the PI3K/AKT and MAPK pathways (Candeias et al., 2012).
Insulin Resistance
Insulin resistance (IR) is characterized by the body’s inability to effectively use the
insulin it produces and, thus, insulin is unable to elicit appropriate nutrient storage after a meal in
its primary target tissues, adipose tissue and the liver (Summers, 2006). Insulin resistance is not
only a key contributor of Type 2 Diabetes Mellitus (T2DM), but has now emerged as a highly
relevant contributor to Alzheimer’s Disease.
Despite the evidence linking IR to Alzheimer’s disease, there are nevertheless relevant
mediators of this connection. A common mediator of IR is the sphingolipid ceramide and its
downstream effects on mitochondrial dysfunction, both of which correlate with the severity of IR
and cognitive decline (Haus et al., 2009; Savica et al., 2016). Ceramides are a sphingolipid that
have a role in the antagonism of mitochondrial function and several different intermediates in the
insulin signaling pathway. In regard to mitochondrial function, increased ceramide levels cause
an increase in the production of reactive oxygen species and therefore induce more oxidative
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stress within different tissues (Summers, 2006). In the brain, mitochondrial dysfunction and the
resulting oxidative stress leads to increased amyloid-beta deposition, which positively regulates
the oxidative stress-mediated deposition of amyloid-beta plaques (Ahmed, Mahmood, & Zahid,
2015).
The common problem with cognitive-declining and diabetic brains is a hypometabolism
of glucose and deficient insulin signaling (i.e. IR). In regards to the deficient insulin signaling,
the exact mechanism of how this happens is unknown, but evidence suggests it not only causes
decreased glucose metabolism, but can induce neurofibrillary degeneration and tau OGlcNAcylation, leading to tau neurofibrillary tangles (Liu, Liu, Grundke-Iqbal, Iqbal, & Gong,
2011).
Critically, as insulin resistance occurs with aging or T2DM, insulin and glucose levels
slowly increase, but this inhibits ketogenesis and prevents the brain from receiving an alternate
energy source to the glucose (Lange et al.). Therefore, the actual insulin response is not what
disrupts the mitochondrial function of the brain, but it’s the IR and disruption, or lack of insulin
signaling, that causes the neurons to be more vulnerable to metabolic stress and neuronal
dysfunction.
Ketones: The Alternate Fuel Source
Ketones, or ketone bodies, are made by the liver and are a family of nutrients, including
acetoacetate, beta-hydroxybutyrate, and acetone. The circulating levels of ketones within the
plasma is dependent on the rate of production, ketogenesis, and utilization, ketolysis. When
insulin levels drop, its inhibition of free fatty acid catabolism from adipose tissue is overcome
and free fatty acids are then released into the plasma. When levels of free fatty acids are high, the
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production of acetyl coenzyme A increases within the liver and the enzyme is then used for
ketogenesis (Fukao, Lopaschuk, & Mitchell, 2004). Ketones, a fat derived substrate, can then
pass into the brain and be used in the mitochondria (Balasse & Féry, 1989).
Ketones are also beneficial for many reasons. Because free fatty acids cannot pass
through the blood brain barrier, the brain is unable to use them as an alternate fuel source, but
this is not the case with ketones (Pardridge, 1991). In addition, ketones can produce a larger
amount of energy in comparison to glucose. This is due to the changes in mitochondrial ATP
production that they induce. Lastly, ketones are able to overcome the block in glycolysis that is
caused by IR (Lange et al.). Unfortunately, insulin and high glucose levels prevent both the
breakdown of free fatty acids and the synthesis of ketone bodies in the liver. Because of the
properties and benefits of ketogenesis, ketogenic diets and ketone supplements have been
suggested as treatments for neuronal diseases such as epilepsy, autism, and Alzheimer’s disease
(Castro et al., 2015; Cunnane et al., 2011; Henderson et al., 2009).
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CHAPTER 2: Insulin Alters Brain Lipid Profile and
Mitochondrial Function in ApoE4 Mice
Sheryl Carr, Annie Trumbull, BreAnna Hutchinson, Blake Dallon, Mitchell Harrison, Harrison
Gray, Jonathan Gibbs, Dane Eskildsen, Jess Kudlacek, Brett Heldt, Craig Clayton, William L.
Holland, Jonathan J. Wisco, Benjamin T. Bikman
Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT
Abstract
Background
Alzheimer’s disease (AD), the most common neurodegenerative disorder worldwide, is
characterized by increased levels of neurofibrillary tangles and amyloid-beta plaques. Evidence
has previously implicated the potent role that insulin resistance plays in the development and
progression of AD, suggesting to some that AD represents a distinct type of diabetes.
Additionally, disparate lines of evidence find a role for alterations in brain mitochondrial
function in AD etiology.
Methods
We sought to test a unifying hypothesis—namely, that hyperinsulinemia promotes
accrual of the sphingolipid ceramide, which, as we’ve previously found, pathologically alters
mitochondrial function. Via daily insulin injections, we induced hyperinsulinemia in ApoE4
mice. In addition to insulin, one group received myriocin injections to inhibit ceramide
biosynthesis.
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Results
We observed significant increases in brain ceramides in the insulin-treated group, which
correlated with disrupted brain mitochondrial function. However, the group receiving myriocin
alone, or, importantly, myriocin with insulin, had normal lipid profiles and apparently normal
mitochondrial bioenergetics.
Conclusions
Altogether, our findings suggest a causative role for insulin in AD etiology via an insulininduced upregulation of ceramide biosynthesis and accrual in the brain.
Background
Brain mitochondrial dysfunction is a hallmark of Alzheimer’s disease (AD). With the
current correlations between insulin resistance (IR) and AD, research has started to look at
insulin’s role within the brain and how IR alters homeostatic brain function. Unlike peripheral
insulin receptors, neuronal insulin receptors and IGF-1 receptors, which also respond to insulin,
within the brain regulate many physiological functions such as food intake, inhibition of hepatic
gluconeogenesis, mitochondrial function, counter-regulation of hypoglycemia, modulation of tau
protein phosphorylation, AβPP metabolism, Amyloid-β clearance, neuronal survival, and
memory (Candeias et al., 2012). Therefore, while insulin has a minor role in glucose metabolism
within the brain, it also maintains a vital role in other neuronal functions. Because of this, insulin
resistance is not only a key contributor of Type 2 Diabetes (T2DM), but has now emerged as
contributor to Alzheimer’s Disease.
A common mediator of IR and mitochondrial dysfunction are ceramides, whose levels
correlate with the severity of IR and cognitive decline (Haus et al., 2009; Savica et al., 2016).
8

Ceramides are a sphingolipid that have a role in the antagonism of mitochondrial function and
several different intermediates in the insulin signaling pathway. In regard to mitochondrial
function, increased ceramide levels cause an increase in the production of reactive oxygen
species and therefore induce more oxidative stress within different tissues (Summers, 2006).
Methods
Animals
Homozygous ApoE4 mice with an average age of 4.5 months were randomly assigned
into one of four treatment groups for 4 weeks: (i) PBS injections (control); (ii) insulin and PBS
injections (INS); (iii) myriocin injections in order to inhibit ceramide synthesis (Myr); and (iv)
insulin and myriocin injections (INS+Myr). All injections were intraperitoneal. Studies were
conducted in accordance with the principles and procedures outlined in the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and were approved by the IACUC
(Institutional Animal Care and Use Committee) at Brigham Young University.
Insulin Tolerance Test
After 4 weeks, mice underwent intraperitoneal insulin tolerance tests. Mice were fasted
overnight and received an injection of insulin (0.75 unit/kg of body weight). Blood glucose was
determined at the times indicated in the figures using the Bayer Contour glucose meter.
Lipid Analysis
In isolating lipids, pellets were suspended in ice-cold chloroform-methanol (1:2),
incubated for 15 min on ice, and then briefly vortexed. Aqueous and organic phases were
separated by the addition of ice-cold water and chloroform. The organic phase was collected in a
9

fresh vial and dried via vacuum centrifugation (Eppendorf Concentrator Plus). Lipids were then
characterized and quantified using shotgun lipidomics on a Thermo ScientificLTQ Orbitrap XL
mass spectrometer, as previously described (Hansen et al., 2014).
Mitochondrial Respiration Protocol
High-resolution O2 consumption was determined at 37°C in permeabilized cells and fiber
bundles, using the Oroboros O2K Oxygraph (Innsbruck, Austria) with MiR05 respiration buffer
as described previously (Pesta & Gnaiger, 2012; Smith et al., 2013). Respiration was determined
by all or parts of the following substrate-uncoupler inhibitor-titration (SUIT) protocol (Jheng et
al., 2012): electron flow through complex I was supported by glutamate malate (10 and 2 mM,
respectively) to determine O2 consumption from proton leak (GML). Following stabilization,
ADP (2.5 mM) was added to determine oxidative phosphorylation capacity (GMP). Succinate
was added (GMSP) for complex III electron flow into the Q-junction. To determine full electron
transport system (ETS) capacity over oxidative phosphorylation in cells, the chemical uncoupler
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) was added (0.05 M followed by
0.025 M steps until maximal O2 flux was reached). Complex II-supported ETS was then
measured by inhibiting complex I with rotenone (Rot; 0.5 M). Last, residual O2 consumption
was measured by adding antimycin A (2.5 M) to block complex III action, effectively stopping
any electron flow. This value provides a rate of respiration that is used as a baseline.
Statistics
Values are reported as means ± the standard errors of the means. Statistical analyses were
conducted by one-way analysis of variance with treatment and set of experiment as factors.
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Student's t test was used for comparisons between groups within each experiment, and
differences were considered to be statistically significant at P < 0.05.
Results
Chronic Insulin Injections Increase Body Weight and Fasting Glucose Levels, While Inducing
Insulin Intolerance
ApoE4 mice received injections of PBS (daily), insulin (daily; 0.75 mg/kg), myriocin
(thrice weekly; 3 mg/kg; MYR), or insulin + myriocin (INS+MYR) at the same time each day
for four weeks. At the end of the treatment, the INS group had the greatest increase in body
weight, though no such effect was noted with the inclusion of myriocin (INS+MYR) (Figure
2.1a). INS also had decreased insulin sensitivity, based on the insulin tolerance test performed
after the 4-week treatment regimen (Figure 2.1b). The PBS, MYR, and INS+MYR groups had
no statistical significance between their changes in their fasting glucose levels (Figure 2.1c). In
addition, fasting glucose levels were elevated in the INS group in comparison to the other three
groups, and insofar as the addition of myriocin prevented this effect, the results suggest that
ceramides play a role in the changing insulin sensitivity and fasting glucose levels due to
myriocin preventing significant changes in these measurements (Figure 2.1c).
Insulin Increases Ceramide Accrual in the ApoE4 Brain
After tissue collection, lipid analysis was completed to determine levels of ceramides
within the brains of each ApoE4 mouse. Upon analysis via shotgun lipidomics/LCMS, it was
found that the INS group had the greatest amount of overall ceramides within the brain, as well
as the specific sub-types of C16:1, C20, C24, and C24:1. Most importantly, myriocin was able to
reduce the ceramide accrual, despite the insulin injections in the INS+MYR group (Figure 2.2).
11

Chronic Insulin Injections Disrupt Brain Mitochondrial Function
To measure mitochondrial function within the brain, respirations were performed on fresh
brain biopsies as described in Figure 2.3b. The GML step determined the oxygen consumption
from the proton leak and malate aspartate shuttle within the mitochondria. There was no
difference in any of the groups in this first step (Figure 2.3a). Next, we determined the oxidative
phosphorylation capacity, this is the GMP, and found that insulin injected group began to fall
behind while the myriocin + insulin group had comparable mitochondrial function to both the
PBS and myriocin only groups (Figure 2.3a). This trend continued in the final GMSp step where
CI and CII function were evaluated (Figure 2.3a).
Therefore, overall respiration, RCR, and CII factor were reduced with insulin treatment
(Figure 2.3a,c,d). The INS + MYR group also had reduced CII factor in comparison to the PBS
group (Figure 2.3d).
Discussion
In mice, we found that prolonged insulin treatment resulted in reduced insulin tolerance,
supporting previous findings that insulin alone, independent of other variables, is capable of
inducing insulin resistance. This observation agrees with evidence from several other reports in
both humans and rodents where hyperinsulinemia from endogenous (e.g., insulinoma) or
exogenous (e.g., injections) sources causes insulin resistance (Del Prato et al., 1994; Henry et al.,
1993; Hodson, Tippetts, & Bikman, 2015; Pontiroli, Alberetto, & Pozza, 1992). This insulindesensitizing effect of prolonged hyperinsulinemia is likely partially mediated via ceramide
accrual, as evidenced by our findings that ceramide inhibition via myriocin was protective
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against the deleterious changes in insulin sensitivities. However, the relevance of ceramides in
mediating hyperinsulinemia-induced changes extend beyond insulin sensitivity.
To further understand the pathology of insulin and ceramides, we looked at brain
ceramide accrual and mitochondrial function insofar as insulin resistance and mitochondrial
dysfunction are key markers of dementia diseases such as AD (Ahmed, Mahmood, & Zahid,
2015; Biessels & Kappelle, 2005; Readnower, Sauerbeck, & Sullivan, 2011). We conclude that
ceramides are a key intermediate in insulin-induced mitochondrial dysfunction in light of the fact
that the mice receiving the ceramide-inhibitor myriocin had relatively normal brain
mitochondrial function, supporting our previous reports of ceramide-induced mitochondrial
dysfunction (Smith et al., 2013). The impairment of energy metabolism, which includes
mitochondrial dysfunction, is a significant characterization of AD and our data adds to previous
data, by indicating ceramide’s key role (Shenk et al., 2009).
In the last 15 years, the increasing prevalence of both AD and T2DM has led to
research demonstrating insulin’s critical role in AD development and the increased risk of
AD caused by T2DM (Liu, Liu, Grundke-Iqbal, Iqbal, & Gong, 2011). Defective insulin
signaling not only effects memory and learning, but is linked with amyloid-beta plaque
formation that causes the displacement of insulin receptors from the plasma membrane,
furthering the IR within the brain (Ahmed et al., 2015). The relationship between IR,
ceramides, and mitochondrial function shown by our research furthers other research
connecting these variables to AD, thereby suggesting a key role of both insulin and
ceramides in AD. Altogether, our findings propose a causative role for insulin in brain
mitochondrial dysfunction via an insulin-induced upregulation of ceramide biosynthesis
and accrual in the brain.
13
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used to determine the specific effect of succinate addition on respiration.
*P<0.05 and **P<0.01 for INS vs. other treatments. #P<0.05 for INS+MYR vs. PBS.
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Figure 2.3cd: Chronic Insulin Injections Disrupt Brain Mitochondrial Function. To measure
mitochondrial respiration (A), samples were treated with: GML, Glutamate (10 mM) + Malate (2 mM);
GMD, + ADP (2.5 mM); GMSD, + Succinate (10 mM). A description of the protocol is shown in B.
Respiratory control ratio (RCR; C) was determined by GMP/GML. Complex II control factor (D) was
used to determine the specific effect of succinate addition on respiration.
*P<0.05 and **P<0.01 for INS vs. other treatments. #P<0.05 for INS+MYR vs. PBS.
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CHAPTER 3: Ketogenic Diet Improves Brain Mitochondrial Function and
Reduces Oxidative Stress in Aged Rats
Sheryl T. Carr, Michael J. Duplisea, Esther K. Wilson, Eric C.K. Cheung, Brian A. Parker,
Conrad K. Ashby, David M. Thomson, Benjamin T. Bikman.
Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT
Abstract
Background
Ketogenic diets (KD) have been promoted extensively for weight loss and health.
Limited evidence also indicates an effect of ketones on improving multiple markers of cognitive
function. However, the effect of a ketogenic diet on brain mitochondrial function remains
unknown.
Methods
Young adult (YA; 5 months old) and old (O; 28 months old) rats were assigned to either
standard chow diets or very-low-carbohydrate, high-fat ketogenic diets for 4 weeks. Following
treatment period, we analyzed brain mitochondrial function.
Results
We observed no effect of KD on altering brain mitochondrial function in YA rats.
However, KD appeared to restore mitochondrial function in O rats. Specifically, O rats fed a
standard diet had significantly higher levels of oxidative stress, while KD-fed O rats had levels
similar to YA rats.
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Conclusions
We conclude that KD improves brain mitochondrial function in aged rats. These results
possibly elucidate and compliment human trials that find improved cognition in states of
elevated ketones.
Background
Unlike peripheral insulin receptors, insulin-mediated neuronal insulin receptors and IGF1 receptors within the brain regulate many physiological functions such as: food intake,
inhibition of hepatic gluconeogenesis, mitochondrial function, counter-regulation of
hypoglycemia, modulation of tau protein phosphorylation, AβPP metabolism, Amyloid-β
clearance, neuronal survival, and memory (Candeias et al., 2012). Therefore, insulin has a
minimal role in glucose metabolism within the brain, but a vital role in other neuronal functions.
When insulin resistance occurs within the brain, defects in glucose metabolism arise.
The low glucose utilization within the brain does not affect peripheral insulin levels and
therefore cannot influence the production of ketones. Ketones are made by the liver and include
acetoacetate, beta-hydroxybutyrate, and acetone (Fukao, Lopaschuk, & Mitchell, 2004). As
insulin resistance progresses with age, insulin and glucose levels slowly increase, inhibiting the
production of ketones from the liver and preventing the brain from receiving an alternate energy
source to the glucose (Jose et al., 2011; Liu, Liu, Grundke-Iqbal, Iqbal, & Gong, 2011; Oya et
al., 2014). Therefore, the actual insulin response is not what disrupts the mitochondrial function
of the brain, but rather the insulin resistance and lack of insulin signaling that makes the neurons
more vulnerable to metabolic stress and subsequent neuronal dysfunction.
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With a ketogenic diet, macronutrients are altered in such a way (i.e. low-carbohydrate,
high-fat) to lower inhibition, and thus, leading to a disinhibition of both lipolysis and
ketogenesis. When the levels of free fatty acids are high due to lipolysis, the production of acetyl
coenzyme A increases within the liver and, due to a general inhibition of pyruvate
dehydrogenase and acetyl-coA carboxylase, the substrate is used for ketogenesis (Fukao et al.,
2004). Ketones can then be used as nutrient energy for all cells with mitochondria, including the
brain, passing through the blood-brain barrier to be readily used by the brain (Balasse & Féry,
1989). In comparison to glucose, ketones are able to produce a larger amount of ATP per unit,
due to an absence of ATP use in ketone catabolism (unlike glucose catabolism). In addition, they
are also able to provide ATP in spite of the block in glycolysis that is caused by IR (Lange et al.).
Unfortunately, insulin and high glucose levels prevent both the breakdown of fat into free fatty
acids and the synthesis of ketone bodies in the liver due to an insulin-induced inhibition of
enzymes involved in b-oxidation. Because of the properties and benefits of ketogenesis,
ketogenic diets and ketone supplements have been suggested as treatments for neuronal diseases
such as epilepsy, autism, and Alzheimer’s disease (Castro et al., 2015; Cunnane et al., 2011;
Henderson et al., 2009).
Methods
Animals
Male rats were obtained from ThermoFisher (344 rats) and were split into two groups:
young adult (YA; 5 month old) and old (O; 28 month old) of male Fisher 344 rats (n = 46/group). Rats were assigned to either standard chow (STD; Evigo Teklad Rodent Diet, 8604;
32% protein, 14% fat, 54% carbohydrate) or ketogenic diet (KETO; Envigo Teklad Custom Diet,
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TD.10911; 22.4% protein, 77.1% fat, 0.5% carbohydrate) for 4 weeks, and weighed weekly.
KETO rats were pair fed isocalorically with STD chow rats within each age group. Studies were
conducted in accordance with the principles and procedures outlined in the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and were approved by the IACUC
(Institutional Animal Care and Use Committee) at Brigham Young University.
Glucose Tolerance Test
After 24 - 25 days on the assigned diet, glucose tolerance testing was performed by
fasting the rats for 6 hours followed by an injection of 1 mg glucose/g BW. Blood glucose
concentration was measured from tail blood immediately before and at 15, 30, 60 and 120
minutes after the glucose injection.
Ketone Measurements
Ketones were measured from tail blood prior to the necessary glucose injections for the
glucose tolerance tests using a blood ketone monitor (Precision Xtra).
Brain Lipid Analysis
In isolating lipids, pellets were suspended in ice-cold chloroform-methanol (1:2),
incubated for 15 min on ice, and then briefly vortexed. Aqueous and organic phases were
separated by the addition of ice-cold water and chloroform. The organic phase was collected in a
fresh vial and dried via vacuum centrifugation (Eppendorf Concentrator Plus). Lipids were then
characterized and quantified using shotgun lipidomics on a Thermo ScientificLTQ Orbitrap XL
mass spectrometer, as previously described (Hansen et al., 2014).
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Mitochondrial Respiration Protocol
High-resolution O2 consumption was determined at 37°C in permeabilized cells and fiber
bundles, using the Oroboros O2K Oxygraph (Innsbruck, Austria) with MiR05 respiration buffer
as described previously (Pesta & Gnaiger, 2012; Smith et al., 2013). Respiration was determined
by all or parts of the following substrate-uncoupler-inhibitor-titration (SUIT) protocol (Jheng et
al., 2012): electron flow through complex I was supported by glutamate malate (10 and 2 mM,
respectively) to determine O2 consumption from proton leak (GML). Following stabilization,
ADP (2.5 mM) was added to determine oxidative phosphorylation capacity (GMP). Succinate
was added (GMSP) for complex III electron flow into the Q-junction. To determine full electron
transport system (ETS) capacity over oxidative phosphorylation in cells, the chemical uncoupler
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) was added (0.05 M followed by
0.025 M steps until maximal O2 flux was reached). Complex II-supported ETS was then
measured by inhibiting complex I with rotenone (Rot; 0.5 M). Last, residual O2 consumption
was measured by adding antimycin A (2.5 M) to block complex III action, effectively stopping
any electron flow. This value provides a rate of respiration that is used as a baseline.
Statistics
Values are reported as means ± the standard errors of the means. Statistical analyses were
conducted by one-way analysis of variance with treatment and set of experiment as factors.
Student's t test was used for comparisons between groups within each experiment, and
differences were considered to be statistically significant at P < 0.05.
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Results
Ketogenic Diet Leads to Weight Loss in Young Rats
After four weeks on the assigned diet, it was found that the ketogenic diet only caused
weight loss in the Y rats (Figure 3.1). The SD Y rats had an increase in weight at the end of the
four weeks. All O rats had a decrease in weight at the end of the four weeks, despite the diet
regimen.
Fasting glucose and plasma ketone levels were measured weekly over the four-week
period while consuming the assigned diet. At the end of four weeks, there was not a statistically
significant difference in any of the groups for either ketones or glucose levels (Figure 3.2).
However, there was a trend of increased plasma ketones in the Y KD rats (Figure 3.2a).
Ketogenic Diet Improved Brain Mitochondrial Function in Old Rats
To measure mitochondria function within the brain, mitochondrial respirations were
performed on fresh brain biopsies. The GML step determined the oxygen consumption from the
proton leak and malate aspartate shuttle within the mitochondria. The O SD rats had lower
mitochondrial function than the Y SD rats (Figure 3.3a). Next, we determined the oxidative
phosphorylation capacity, this is the GMP, and found that the O KD rats’ brain mitochondria
function began to improve significantly in comparison to the O SD rats. The O SD rats still had
lower mitochondrial function than the Y SD rats (Figure 3.3a). This trend continued in the final
GMSp step where CI and CII function were evaluated (Figure 3.3a). The respiratory control ratio
(RCR; GMP/GML) was a post-hoc analysis done to measure overall mitochondrial fitness
(Figure 3.3b). The RCR shows that the O KD rats had better mitochondrial fitness than the O SD
rats.
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Lastly, oxidative stress was measured via production of H2O2 within the brains. The O SD
rats had the highest levels of oxidative stress (Figure 3.4). However, the O KD had a statistically
significant drop in H2O2 production within the brain in comparison to the O SD rats.
Discussion
Our most relevant finding was that a ketogenic diet (KD) improved brain mitochondrial
function in a rat model of aging. Specifically, the brains from KD-fed aged rats had substantially
lower rates of H2O2 production, indicating reduced oxidative stress. Because insulin resistance
occurs with aging, the ketogenic diet is a viable therapy option in order to bypass the disrupted
glucose metabolism that occurs in the mitochondria of the aged brain, and may reveal a pathway
to help maintain nervous function and prevent neurodegeneration (Candeias et al., 2012;
Cunnane et al., 2011; Jose et al., 2011).
These findings in the rodent model may provide a mechanism to better understand the
results of related human studies. In particular, in older adults with mild cognitive impairment, 6weeks on a low carbohydrate diet improved verbal memory performance in comparison to those
on a high carbohydrate diet. This low-carbohydrate diet also reduced fasting glucose levels,
fasting insulin levels, waist circumference, and weight in comparison to those eating a high
carbohydrate diet (Krikorian et al.). In addition, direct administration of the ketone βhydroxybutyrate into the brain of rats has been shown to prevent amyloid-beta plaque deposition,
neuronal apoptosis, and decreased oxidative stress, therefore improving mitochondrial function
and preventing markers of age-related pathologies such as Alzheimer’s disease (Xie, Tian, Wei,
& Liu, 2015). Our data corroborates this previous work, as we found that a low carbohydrate,
ketogenic diet improved brain mitochondrial function in old rats.
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In the Y rats, the KD caused a significant amount of weight loss, in comparison to the Y
rats on the SD, who gained weight at the end of the 4 weeks. In contrast to Y rats, there was no
difference in weight loss between the SD and KD old rats. This was surprising, as ketogenic
diets have been previously shown to reduce weight over time, even in seniors (Krikorian et al.;
Saslow et al., 2014; Saslow et al., 2017). A possible explanation for this is that the rats were
simply too old and were already losing weight due to age-related wasting. We may have
benefited from using rats that were not as old in order to better measure the effects of the KD on
their weight.
In addition, it was surprising that there was no difference in plasma ketone levels in any
of the groups, although there was a trend of the Y KD rats having increased plasma ketones.
Previous studies have shown that rats are able to be induced into ketosis using a lowcarbohydrate, high fat diet in a three to four week time period, similar to the experimental time
frame we used (Bielohuby et al., 2010; Xu et al., 2010). It is possible that our protein
composition of 22.4% was too high, as it has been found that only rats fed ketogenic diets very
high in fat and low in protein are clearly in ketosis while rats fed high fat and normal protein
diets (in comparison to SD) have no signs of ketosis (Bielohuby et al., 2010). Exogenous ketone
supplements have been used to induce ketosis by increasing plasma β-hydroxybutyrate levels
(Kesl et al., 2016). This has also been seen in elderly patients suffering from mild to moderate
AD, where researchers administered an oral ketone supplement (AC-1202, a form of medium
chain triglycerides) and found increased ketone plasma levels due to the supplement, which also
correlated with increased cognitive performance scores (Henderson et al., 2009). Based on these
mentioned studies, it is unclear exactly why our KD rats did not have elevated plasma ketones,
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but the improved brain mitochondrial function within the O KD rats suggests that the ketones
were elevated enough to overcome the decreased glucose metabolism within the aged brain.
In conclusion, these findings reveal that a carbohydrate-restricted, ketogenic diet is
effective at reducing oxidative stress and improving mitochondrial function in the brain of rat
model of aging. The implications of these findings may assist in directing future therapies to
help mitigate the loss of cognitive function in human aging and metabolic disease.
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Figure 3.1: Ketogenic Diet Induced Weight Loss in Young Rats. While on the diet regimen, rats were
weighted weekly and recorded. This figure represents the overall body weight change in each group.
*P<0.05 for Y SD vs. Y KD
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Figure 3.2: Ketogenic Diet Did Not Alter Plasma Ketones or Fasting Glucose Levels. After 24 - 25 days
on the assigned diet, fasting glucose and plasma ketone levels were measured, but there was no
statistically significant difference.
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Figure 3.3: Ketogenic Diet Improved Brain Mitochondrial Function in Old Rats. To measure
mitochondrial respiration (a), samples were treated with: GML, Glutamate (10 mM) + Malate (2 mM);
GMD, + ADP (2.5 mM); GMSD, + Succinate (10 mM). Respiratory control ratio (RCR; b) was
determined by GMP/GML. *P<0.05 for O SD vs. Y SD. #P<0.05 for O SD vs. O KD.
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Figure 3.4: Ketogenic Diet Reduced H2O2 Production in Old Rats. *P<0.05 for O SD vs. Y SD. #P<0.05
for O SD vs. O KD.
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CHAPTER 4: General Discussion and Future Directions
Collectively, the data from these studies enhance the findings of existing work that not
only implicate insulin resistance (IR) and ceramides as key players in brain mitochondrial
dysfunction, but also reveal a growing role for ketogenesis as a pathway that may be exploited to
mitigate some of the degrading effects of IR. In particular, as insulin resistance occurs with age,
a ketogenic diet is a viable treatment therapy to bypass the altered brain glucose metabolism and
insulin signaling, both fueling the brain and helping maintain proper mitochondrial function, as
seen in Chapter 3, and prevent further neurodegeneration, such as that found in AD (Candeias et
al., 2012).
We first explored how insulin resistance and its resulting ceramide accumulation can
impact mitochondrial function within the brain. It has previously been found that ceramide
negatively influences mitochondrial function in a variety of cells and tissues (Hodson, Tippetts,
& Bikman, 2015; Smith et al., 2013; Summers, 2006). In our study, we found that chronic insulin
injections induced insulin resistance and thereby lead to brain mitochondrial dysfunction in an
Alzheimer’s mouse model. This mitochondrial dysfunction within the brain required ceramides
in order to occur, as evidence by the myriocin preventing insulin-induced mitochondrial
dysfunction.
Although we did not measure how these conditions affected behavioral responses, it is
reasonable to hypothesize that the insulin-induced changes in mitochondrial function would
correlate with decreased cognitive function, thereby supporting the mitochondrial cascade
hypothesis of AD (S. Cunnane et al., 2011; Readnower, Sauerbeck, & Sullivan, 2011; Swerdlow,
2012).
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Historically, AD has been characterized by the build-up of amyloid-beta plaques and tau
neurofibrillary tangles (Huang, 2006). However, with new research tying TIID and AD together,
and advanced experimental techniques, the mitochondrial cascade hypothesis of AD and
cognitive decline has come forth (Ahmed, Mahmood, & Zahid, 2015; Biessels & Kappelle,
2005; Hoyer, 2004; Readnower et al., 2011; Zhao & Townsend, 2009). Our research supports
this mitochondrial cascade hypothesis of decreased brain mitochondrial function, especially in
regard to mitochondrial dysfunction caused by IR, whether it be due to chronic insulin injections
mimicking TIID or old age.
Since IR naturally occurs in aged brains, our next step was to evaluate whether not a
ketogenic diet could overcome the IR and ceramide induced mitochondrial dysfunction. Using O
rats, we were able to observe the benefits of a KD on brain mitochondrial function and oxidative
stress levels. As mentioned previously, we did not have the ability to measure how the KD
effected cognitive function or behavior, but based on our data and published studies it is
reasonable to assume that the KD would improve memory and their ability to complete
experimental tasks as it has in human studies, many of which used AD patients (S. C. Cunnane et
al., 2016; Henderson et al., 2009; Lange et al.; Xie, Tian, Wei, & Liu, 2015).
AD is the 6th leading cause of death, responsible for mortality in one in three seniors.
Unfortunately, current trends are likely to continue as the prevalence of dementia increases
worldwide (Ballard et al.). A source of clinical frustration is the inability to definitively
diagnose the disease in early stages, which is doubly frustrating when combined with the lack of
established treatments. However, with an understanding of the interworking’s of insulin and
ketones within the brain, scientists and practitioners can better understand cognitive impairment
and how to prevent cognitive function from worsening.
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To build on our current research, we would like to determine whether a ketogenic diet
can benefit the brain mitochondrial function in mouse models of AD, as well young rodents that
have received chronic insulin injections. In addition, we would like to create a behavioral assay
to better understand the cognitive effects of such treatments.
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